West Enclave Merger Corp. reported a first-quarter 2026 net loss of $40.4M, equivalent to basic and diluted net loss per ordinary share of $(0.01), as the blank-check company continues preparatory activities ahead of a target business combination. The firm has not generated operating revenues to date.
Financial Highlights
- Net income: $(40.4M) net loss for Q1 2026 (three months ended Mar. 31, 2026).
- Diluted EPS: $(0.01) per share for Q1 2026 (basic and diluted net loss per ordinary share).
Business Highlights
- Capital raise and trust funding: Completed an IPO and private placements, placing $116.15M in trust to fund a target business combination.
- Operational status: No operating revenues to date; activities have focused on target identification, IPO preparation and due diligence.
- Post-IPO trading structure: Units separated for trading into ordinary shares and rights, enabling separate market liquidity beginning May 13, 2026.
- Use of proceeds and growth plan: Trust funds are earmarked for an acquisition and working capital; cash outside the trust will be used for target evaluation and transaction-related costs.
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.